Ricardo Gonzalez-Calderon
Santander, CB, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Efficiency of nanovaccines compared with antibiotic therapy in the prevention and immunomodulation of listeriosis.
Journal: Emerging microbes & infections
Published: July 24, 2026
Glyceraldehyde-3-phosphate Dehydrogenase Common Peptides of Listeria monocytogenes, Mycobacterium marinum and Streptococcus pneumoniae as Universal Vaccines.
Journal: Vaccines
Published: February 14, 2021
A Comparison Between Recombinant Listeria GAPDH Proteins and GAPDH Encoding mRNA Conjugated to Lipids as Cross-Reactive Vaccines for Listeria, Mycobacterium, and Streptococcus.
Journal: Frontiers in immunology
Published: November 23, 2020
Epitopes for Multivalent Vaccines Against Listeria, Mycobacterium and Streptococcus spp: A Novel Role for Glyceraldehyde-3-Phosphate Dehydrogenase.
Journal: Frontiers in cellular and infection microbiology
Published: June 16, 2020
Dendritic cell therapy in melanoma.
Journal: Annals of translational medicine
Published: November 09, 2017
Pregnancy Vaccination with Gold Glyco-Nanoparticles Carrying Listeria monocytogenes Peptides Protects against Listeriosis and Brain- and Cutaneous-Associated Morbidities.
Journal: Nanomaterials (Basel, Switzerland)
Published: January 01, 2016
Novel nanoparticle vaccines for Listeriosis.
Journal: Human vaccines & immunotherapeutics
Published: August 08, 2015
Exceptional antineoplastic activity of a dendritic-cell-targeted vaccine loaded with a Listeria peptide proposed against metastatic melanoma.
Journal: Oncotarget
Published: July 13, 2015
Last Updated: 09/26/2026